Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Brittenham, Gary M.
Weiss, Günter
Brissot, Pierre
Lainé, Fabrice
Guillygomarc'h, Anne
Guyader, Dominique
Moirand, Romain
and
Deugnier, Yves
2000.
Clinical Consequences of New Insights in the Pathophysiology of Disorders of Iron and Heme Metabolism.
Hematology,
Vol. 2000,
Issue. 1,
p.
39.
Drakesmith, Hal
and
Townsend, Alain
2000.
The structure and function of HFE.
BioEssays,
Vol. 22,
Issue. 7,
p.
595.
Brittenham, Gary M.
Weiss, Günter
Brissot, Pierre
Lainé, Fabrice
Guillygomarc'h, Anne
Guyader, Dominique
Moirand, Romain
and
Deugnier, Yves
2000.
Clinical Consequences of New Insights in the Pathophysiology of Disorders of Iron and Heme Metabolism.
Hematology,
Vol. 2000,
Issue. 1,
p.
39.
Liu, Zu D.
and
Hider, Robert C.
2002.
Design of clinically useful iron(III)‐selective chelators.
Medicinal Research Reviews,
Vol. 22,
Issue. 1,
p.
26.
Acton, Ronald T.
and
Barton, James C.
2004.
Encyclopedia of Medical Genomics and Proteomics.
p.
605.
Hahn, Jan-Uwe
Steiner, Michael
Bochnig, Sabine
Schmidt, Hartmut
Schuff-Werner, Peter
and
Kerner, Wolfgang
2006.
Evaluation of a Diagnostic Algorithm for Hereditary Hemochromatosis in 3,500 Patients With Diabetes.
Diabetes Care,
Vol. 29,
Issue. 2,
p.
464.
Dunet, Diane O.
and
Reyes, Michele
2006.
Stakeholder-focused evaluation of an online course for health care providers.
Journal of Continuing Education in the Health Professions,
Vol. 26,
Issue. 4,
p.
257.
Girard, A.
De Sagazan, O.
Le Bihan, F.
Geneste, F.
Mohammed-Brahim, T.
Dauphas, S.
Brissot, P.
and
Guguen-Guillouzo, C.
2008.
Electrical quantification of low concentrations of specific protein in complex biological solutions.
p.
638.
Reyes, Michele
Dunet, Diane O.
Isenberg, Karen Bandel
Trisolini, Michael
and
Wagener, Diane K.
2008.
Family‐based Detection for Hereditary Hemochromatosis.
Journal of Genetic Counseling,
Vol. 17,
Issue. 1,
p.
92.
Barton, James C.
and
Acton, Ronald T.
2009.
Hemochromatosis and Vibrio vulnificus Wound Infections.
Journal of Clinical Gastroenterology,
Vol. 43,
Issue. 9,
p.
890.
Oktar, S.
Yönden, Z.
Aydin, M.
Ilhan, S.
Alçin, E.
and
Öztürk, O. H.
2009.
Protective effects of caffeic acid phenethyl ester on iron-induced liver damage in rats.
Journal of Physiology and Biochemistry,
Vol. 65,
Issue. 4,
p.
339.
Kirk, L.
Bird, J.
Ramadan, S.
Samad, A.
Adebayo, G.
Lourens, W.
and
Williams, J.
2009.
Haemochromatosis gene frequency in a control and diabetic Irish population.
Irish Journal of Medical Science,
Vol. 178,
Issue. 1,
p.
39.
Kontoghiorghes, George J.
Spyrou, Aspasia
and
Kolnagou, Annita
2010.
Iron Chelation Therapy in Hereditary Hemochromatosis and Thalassemia Intermedia: Regulatory and Non Regulatory Mechanisms of Increased Iron Absorption.
Hemoglobin,
Vol. 34,
Issue. 3,
p.
251.
Zacharski, L. R.
2010.
Hemochromatosis, iron toxicity and disease.
Journal of Internal Medicine,
Vol. 268,
Issue. 3,
p.
246.
Mandeville, Joseph B.
2012.
Neural Metabolism In Vivo.
Vol. 4,
Issue. ,
p.
547.
Behera, T.
Swain, P.
Rangacharulu, P. V.
and
Samanta, M.
2014.
Nano-Fe as feed additive improves the hematological and immunological parameters of fish, Labeo rohita H..
Applied Nanoscience,
Vol. 4,
Issue. 6,
p.
687.
Siddiqui, Aazim A.
and
Eghrari, Allen O.
2014.
Encyclopedia of Ophthalmology.
p.
1.
de Graaff, Barbara
Neil, Amanda
Sanderson, Kristy
Si, Lei
Yee, Kwang Chien
and
Palmer, Andrew J.
2015.
A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis.
Applied Health Economics and Health Policy,
Vol. 13,
Issue. 5,
p.
469.
Hider, Robert C.
Kong, Xiaole
Abbate, Vincenzo
Harland, Rachel
Conlon, Kelly
and
Luker, Tim
2015.
Deferitazole, a new orally active iron chelator.
Dalton Transactions,
Vol. 44,
Issue. 11,
p.
5197.
de Graaff, Barbara
Neil, Amanda
Sanderson, Kristy
Yee, Kwang Chien
and
Palmer, Andrew J.
2016.
Quality of life utility values for hereditary haemochromatosis in Australia.
Health and Quality of Life Outcomes,
Vol. 14,
Issue. 1,